A Phase II Trial of Regorafenib in Patients with Advanced Ewing Sarcoma and Related Tumors of Soft Tissue and Bone: SARC024 Trial Results
Cancer Medicine(2022)
Key words
(5),CIC-DUX4,clinical trial,Ewing sarcoma,regorafenib
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined